AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


25 September 2020

Europe may face an empty medicine cabinet in the fight against antimicrobial resistance

25 September 2020

Antimicrobial Resistance & Europe: What Happened?

25 September 2020

Key genetic clue missing in fight against superbugs

24 September 2020

WHO report supports global use of genetic sequencing to fight antimicrobial resistance

24 September 2020

‘Pharma resistance’ to battle superbugs

23 September 2020

New high-speed test shows how antibiotics combine to kill bacteria

23 September 2020

CARB-X FUNDS GSK TO DEVELOP A NEW DRUG FOR URINARY TRACT INFECTIONS (UTI) CAUSED BY ESCHERICHIA COLI BACTERIA

22 September 2020

Recommended Post-Market Incentive Strategies to Support the Development of Innovative Antibiotics

19 September 2020

Networks of Resistance: Small RNA Control of Antibiotic Resistance

18 September 2020

How Managing Data Effectively Helps Fight Antimicrobial Resistance

18 September 2020

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

12 September 2020

Peptilogics Receives FDA Orphan Drug Designation for Novel Peptide Therapy for the Treatment of Prosthetic Joint Infections

9 September 2020

Evolutionary Approaches to Combat Antibiotic Resistance: Opportunities and Challenges for Precision Medicine

4 September 2020

Scientists develop new compound which kills both types of antibiotic resistant superbugs

1 September 2020

BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics

28 August 2020

THE NATIONAL ANTIMICROBIAL RESISTANCE MONITORING SYSTEM

28 August 2020

The antibiotic paradox: why companies can’t afford to create life-saving drugs

28 August 2020

Taking the next-gen step: comprehensive antimicrobial resistance detection from Burkholderia pseudomallei

24 August 2020

Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistance

10 July 2020

Addressing the crisis in antibiotic development

9 July 2020

Can game theory help detect drug-resistant bacteria?

8 July 2020

Update from WHO and Pew Charitable Trusts: Urgent Action Needed to Accelerate Antibiotic Development

7 July 2020

Researchers develop software to find drug-resistant bacteria

7 July 2020

Chess with bacteria

3 July 2020

New technique in which drugs make bacteria glow could help fight antibiotic resistance

1 July 2020

Current state of the art in rapid diagnostics for antimicrobial resistance

1 July 2020

CARB-X FUNDS ELIGO BIOSCIENCE TO DEVELOP CRISPR-BASED THERAPEUTICS DERIVED FROM BACTERIOPHAGES TO KILL SUPERBUGS AND PREVENT DEADLY INFECTIONS IN TRANSPLANT PATIENTS

1 July 2020

An Analysis of Antibacterial Drug Development Trends in the US, 1980 – 2019

27 June 2020

Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award

24 June 2020

CARB-X FUNDS UNIVERSITY OF QUEENSLAND TO ACCELERATE THE DEVELOPMENT OF A NEW CLASS OF LAST-RESORT ANTIBIOTICS TO TREAT DEADLY SUPERBUG INFECTIONS

23 June 2020

WAAW from 18-24 November, 2020

23 June 2020

CARB-X EXPANDS AWARDS TO AMICROBE BY $4.6M TO ACCELERATE DEVELOPMENT OF TWO DISTINCT AMICIDIN-Β TOPICAL ANTIMICROBIAL PRODUCTS

22 June 2020

AMR, the unstoppable assassin

22 June 2020

Antimicrobial Peptides: The future weapon in fight against antibiotic resistance

22 June 2020

Innovative Metagenomics Study Maps Out Antibiotic Resistance Genes from Hospital Environment Microbiomes

18 June 2020

CARB-X FUNDS MODULE INNOVATIONS TO DEVELOP A SIMPLE TEST TO DIAGNOSE URINARY TRACT INFECTIONS (UTI) AND IDENTIFY SUPERBUGS CAUSING THE INFECTION WITHIN 2 HOURS

18 June 2020

World-first scheme underway to tackle AMR and protect UK patients

16 June 2020

Developing antimicrobial stewardship programs using AI models to ensure optimal selection of antibiotics

15 June 2020

Antibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and Development

15 June 2020

A View from the Wellcome Trust Drug-Resistant Infections Priority Programme: Creating a Sustainable Research and Development Ecosystem to Meet the Global Need for Antibiotics

15 June 2020

How to Stimulate and Facilitate Early Stage Antibiotic Discovery

15 June 2020

NIAID’s Comprehensive Support Mechanisms for Antibiotic Development

15 June 2020

The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development

15 June 2020

On the Road to Discovering Urgently Needed Antibiotics: So Close Yet So Far Away

15 June 2020

The Antibacterial Research and Development Pipeline Needs Urgent Solutions

9 June 2020

Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities

9 June 2020

The REPAIR Impact Fund launches global call for new investment proposals to fight AMR

6 June 2020

FDA Approves Merck’s RECARBRIO™ for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

5 June 2020

A financial model for an impact investment fund for the development of antibacterial treatments and diagnostics

5 June 2020

A financial model for an impact investment fund for the development of antibacterial treatments and diagnostics



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed